HomeCSPC Pharmaceutical Group Limited

Trade CSPC Pharmaceutical Group Limited - 1093 CFD

Market is not available at the momentMarket information is presented
as of 2026-11-18T07:46:52+00:00
Trading Conditions
Type
This financial market is available for CFD trading.
Learn more about:CFDs
CFD
Spread0.1
Long position overnight funding adjustment
Long position overnight funding adjustment

Margin. Your investment
HK$1,000.00
Overnight funding adjustment
Charges from full value of position
-0.01830 %
(-HK$1.83)

Trade size with leverage ~ HK$10,000.00

Money from leverage ~ $HK$9,000.00


-0.01830%
Short position overnight funding adjustment
Short position overnight funding adjustment

Margin. Your investment
HK$1,000.00
Overnight funding adjustment
Charges from full value of position
-0.00362 %
(-HK$0.36)

Trade size with leverage ~ HK$10,000.00

Money from leverage ~ $HK$9,000.00


-0.00362%
Overnight funding adjustment time22:00 (UTC)
CurrencyHKD
Min traded quantity10
Margin10.00%
Stock exchangeHong Kong
Commission on trade10%
Guaranteed stop premium
A guaranteed stop-loss (GSL) fee is only charged if the GSL is triggered. Please consult the Charges and Fees section of our website for more details.
1%

1Our charge for executing your trade is the spread, the difference between the buy and sell price. Please consult the Charges and Fees section of our website for further information

Key Stats
Prev. Close7.85
Open7.85
1-Year Change0.64%
Day's Range7.55 - 7.95

Trade CSPC Pharmaceutical Group Limited - 1093

CSPC Pharmaceutical Group Limited, an investment holding company, manufactures and sells pharmaceutical products in the People's Republic of China, other Asian regions, the Americas, Europe, and internationally. The company operates through Finished Drugs, Antibiotics, Vitamin C, and Caffeine and Others segments. It offers NBP soft capsules and injections for acute ischemic stroke; Oulaining capsules and injections to treat mild to moderate memory and mental impairment resulting from vascular dementia, senile dementia, and brain trauma; Xuanning for hypertension; Duomeisu for lymphoma, multiple myeloma, ovarian and breast cancers, and other malignant tumors; Jinyouli to prevent leucopenia and infection induced by chemotherapy; Ailineng for nerve glioma and brain metastases, and adjuvant treatment of malignant pleural and peritoneal effusion; and Nuolining for chronic myelocytic and acute lymphoblastic leukemia. The company also provides generic drugs, including Ouyi for anti-inflammatory, Gubang to treat osteoporosis, and Weihong for various infections, as well as Guoweikang, a vitamin C supplement tablets; traditional Chinese medicine; and antibiotics comprising Amoxicillin and Ampicillin capsules, Ceftriaxone and Cefazolin sodium injections, and Meropenum injections. In addition, the company offers antibiotics, vitamin C, and caffeine APIs; and researches and develops various products with focus on the therapeutic areas of cardio-cerebrovascular diseases, metabolic diseases, oncology, psychiatry, and neurology. Further, it provides pharmaceutical research and development, and property holding services, as well as storage, sourcing, and distribution services; and sewage products and by-products. The company was formerly known as China Pharmaceutical Group Limited and changed its name to CSPC Pharmaceutical Group Limited in March 2013. CSPC Pharmaceutical Group Limited was founded in 1997 and is headquartered in Shijiazhuang, the People's Republic of China.

User feedback and ratings

Showing our 4 & 5 star reviews. The specific details of the user have been intentionally anonymised to safeguard their privacy pursuant to GDPR requirements.

Ready to join a leading broker?

1. Create your account2. Make your first deposit3. Start when you’re ready